Cerity Partners’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2M Sell
205,071
-21,430
-9% -$2.13M 0.03% 436
2026
Q1
$21.3M Buy
226,501
+1,585
+0.7% +$158K 0.03% 429
2025
Q4
$22.2M Buy
224,916
+21,916
+11% +$2.12M 0.03% 393
2025
Q3
$17.2M Buy
203,000
+38,736
+24% +$3.06M 0.03% 412
2025
Q2
$11.2M Buy
164,264
+31,561
+24% +$2M 0.02% 498
2025
Q1
$8.04M Buy
132,703
+67,495
+104% +$4.71M 0.02% 568
2024
Q4
$4.47M Buy
65,208
+46,051
+240% +$3.28M 0.01% 756
2024
Q3
$1.27M Buy
19,157
+5,537
+41% +$353K ﹤0.01% 1299
2024
Q2
$826K Sell
13,620
-8,705
-39% -$493K ﹤0.01% 1312
2024
Q1
$1.27M Buy
22,325
+17,286
+343% +$1.04M ﹤0.01% 1164
2023
Q4
$316K Buy
+5,039
New +$285K ﹤0.01% 1489

Other funds holding INCY

Cerity Partners's INCY Position: Q2 2026 in Review

Cerity Partners reduced its Incyte (INCY) stake by 9.5% in Q2 2026, selling an estimated $2.13M and leaving 205,071 shares worth $23.2M. The position accounts for 0.03% of the portfolio, ranked #436.

Cerity Partners first reported a position in INCY in Q4 2023 and has held it in 11 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Cerity Partners held 205,071 shares of Incyte worth $23.2M as of Q2 2026.
  • Cerity Partners sold 21,430 Incyte shares in Q2 2026, an estimated $2.13M.
  • Incyte made up 0.03% of Cerity Partners's portfolio in Q2 2026, its #436 holding.
  • Cerity Partners first reported a position in Incyte in Q4 2023 and has held it in 11 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.